论文部分内容阅读
目的:探讨灯盏花素治疗急性脑梗死的临床效果。方法:选取2010年6月至2012年6月我院收治的急性脑梗死患者140例,随机分成两组,观察组和对照组,每组70例,观察组患者采取灯盏花素的治疗方法进行治疗,采取48毫克灯盏花素和480毫升生理盐水静滴的方法,对照组患者采用注射18毫升复方丹参液和静滴480毫升生理盐水的治疗方法,对比观察两组患者的临床治疗效果。结果:经过观察对比,观察组患者的治疗有效率为94.3%,对照组患者的治疗有效率为74.3%,观察组患者的治疗有效率明显高于对照组,且观察组患者的日常生活质量明显高于对照组,差异具有统计学意义(P<0.05)。结论:灯盏花素治疗急性脑梗死是非常有效的,可以大大改善患者的生活质量,临床效果比复方丹参注射液要好,效果显著,值得临床推广。
Objective: To investigate the clinical effect of breviscapine in the treatment of acute cerebral infarction. Methods: A total of 140 acute cerebral infarction patients admitted to our hospital from June 2010 to June 2012 were randomly divided into two groups: observation group and control group, with 70 cases in each group. Patients in observation group were treated with breviscapine Treatment, taking 48 milligrams of Breviscapine and 480 ml of normal saline intravenous drip method, the control group of patients with injection of 18 ml of compound Salvia miltiorrhiza and intravenous infusion of 480 ml of saline treatment were compared between the two groups of patients with clinical treatment. Results: After observation and comparison, the effective rate of treatment was 94.3% in observation group and 74.3% in control group, the treatment efficiency in observation group was significantly higher than that in control group, and the quality of daily life in observation group was significantly Higher than the control group, the difference was statistically significant (P <0.05). Conclusion: Breviscapine is very effective in the treatment of acute cerebral infarction, which can greatly improve the quality of life of patients. The clinical effect is better than compound Danshen injection and the effect is remarkable. It is worthy of clinical promotion.